Hypoplastic Left Heart Syndrome (and the single ventricle repair) - PowerPoint PPT Presentation

About This Presentation
Title:

Hypoplastic Left Heart Syndrome (and the single ventricle repair)

Description:

Hypoplastic Left Heart Syndrome (and the single ventricle repair) Henaro Sabino, MD Sibley Heart Center Cardiology at Children s Healthcare of Atlanta; Emory University – PowerPoint PPT presentation

Number of Views:2494
Avg rating:3.0/5.0
Slides: 71
Provided by: atlantasch
Category:

less

Transcript and Presenter's Notes

Title: Hypoplastic Left Heart Syndrome (and the single ventricle repair)


1
Hypoplastic Left Heart Syndrome (and the single
ventricle repair)
  • Henaro Sabino, MD
  • Sibley Heart Center Cardiology at Childrens
    Healthcare of Atlanta Emory University

2
CHEST PAIN, SYNCOPE
  • IM COMIN HOME!

3
GOALS
  • Appreciation of history of Hypoplastic Left Heart
    Syndrome.
  • Basic anatomy physiology.
  • (DE-mystify Hypoplastic Left Heart Syndrome.)
  • Understand the LOGIC behind the management of
    HLHS ( single ventricle lesions in general).
  • KEEP YOU ALL AWAKE FOR THE NEXT 1.25 HOURS.

4
Hypoplastic Left Heart Syndrome
  • Spectrum of underdevelopment of the left
    ventricular cavity.
  • Have underdeveloped aortic mitral valves
    (stenosis or atresia).
  • Left ventricle is unable to support systemic
    circulation (and, therefore, right ventricle is
    used as the single ventricle).

5
History of HLHS
  • First described by Maurice Lev in 1952.
  • Term used by Noonan Nadas in 1958.
  • Options offered
  • Comfort care
  • Staged palliative repair, i.e. Norwood
    procedure
  • First successful 3-stage completion in 1983
    (after multiple surgeries from 1979).
  • Cardiac transplant
  • First successful cardiac transplant Bailey,
    Nov. 1985

6
1980s
7
Xenotransplantation, Baby Fae
  • Dr. Leonard Bailey, Loma Linda University Medical
    Center, November 1984.
  • http//www.babyfae.com

8
Anatomy
9
HLHS Epidemiology
  • Low incidence of 1.6 to 3.6 per 10,000 live
    births, BUT causes 23 or cardiac deaths during
    1st week of life and 15 during the 1st month of
    life.
  • Makes up about 2-4 of congenital heart disease.
  • More commonly males (55 to 67).
  • With ONE affected child, recurrence risk is about
    0.5 to 2.
  • 12 prevalence of left-sided obstructive lesions
    in 1st degree relatives.
  • 15-30 incidence of genetic syndromes and
    extracardiac anomalies in patients w/HLHS.
  • Genetic markers dHAND, HRT1, HRT2, NOTCH.
  • Moss Adams, 2008.

10
PATHOPHYSIOLOGY
  • Cardiac development Flow begets growth.
  • Altered flow through the left side of the heart
  • Reduced/altered flow across the foramen ovale.
  • Aortic or mitral obstruction.

11
Typical Clinical Presentation
  • Known Congenital Heart Defect
  • Prenatal Diagnosis
  • Unknown Congenital Heart Defect
  • Normal pregnancy, labor and delivery
  • Clinically doing okay until the PDA closes
  • Cyanosis that does not improve with oxygen
  • Many have no other obvious anomalies

12
DUCTAL-DEPENDENT LESION
  • PDA needed to
  • Provide systemic perfusion
  • HLHS
  • Critical aortic stenosis
  • Provide pulmonary blood flow
  • Tricuspid atresia
  • Pulmonary atresia
  • Provide mixing of oxygenated deoxygenated blood
  • Transposition of the Great Vessels

13
Hyperoxitest
  • ABG is measured on room air.
  • Patient is placed on 100 oxygen (intubated) for
    10-15 minutes, then ABG is repeated.
  • If problem is respiratory (i.e. hypoventilation),
    then PaO2 improves (usually above 200mmHg).
  • If problem is cardiac (i.e. right-to-left
    intracardiac shunt), there is little improvement
    of PaO2.
  • Primary pulmonary hypertension may also result in
    little improvement of PaO2.
  • (Oxygen may hasten closure of PDA!)

14
Positive Hyperoxitest
  • Seriously consider initiation of prostaglandin
    (PGE) at a low dose (0.03 mcg/kg/min) until
    diagnosis is confirmed.

15
Initial Assessment
  • ALWAYS
  • A - Airway
  • B - breathing
  • C circulation
  • CXR and ECG usually not very helpful in Dx.

16
Physical Findings
  • Comfortable or in distress?
  • Cyanosis w/out respiratory distress is cardiac
    until proven otherwise
  • Active or lethargic?
  • Cyanosis?
  • Degree - saturation usually lt85 to be seen
  • Anemia makes cyanosis difficult to notice
  • Pallor
  • Vasoconstriction from circulatory shock
  • Perfusion and Peripheral pulses
  • End organs (i.e. watch UOP)

17
Respiratory Status
  • Tachypnea but with minimal distresscardiac until
    proven otherwise.

18
Respiratory Status
  • Respiratory distress
  • Inability of the respiratory system to compensate
    for the metabolic acidosis
  • Concurrent respiratory disease
  • Unrelenting metabolic acidosis - decreased
    cardiac function
  • Exhaustion

19
Assisted Ventilation
  • Intubate if
  • Impending respiratory failure
  • Potentially not necessary to intubate just for
    PGE therapy if ground transport
  • Intubate for air transport in PGE dependent
    babies

20
Assisted Ventilation
  • Ventilation strategy
  • Volume ventilation if possible to maintain
    consistent minute ventilation in the face of
    changing lung compliance
  • Bigger tidal volumes compared to premature
    newborns (10 cc/kg) lower rates
  • No need to over-ventilate
  • 40/40/40 club

21
Arterial Blood Gases
  • In congenital heart disease typically
  • Compensated or partially compensated metabolic
    acidosis
  • Arterial PO2 usually low lt50 with cyanotic heart
    diseasebut not always
  • If PCO2 is rising, think respiratory failure - be
    ready to intubate!

22
Blood Gases
Arterial Capillary Venous
PH accurate accurate lower PO2 accurate invari
able lower PCO2 accurate accurate higher HCO3
(calculated) accurate accurate accurate
23
Oxygen
  • Oxygen is a drug - use it with respect
  • Oxygen is a pulmonary vasodilator
  • May worsen pulmonary congestion
  • Oxygen is a stimulus for the PDA to close
  • May worsen ductal dependent lesions by speeding
    up closure of the PDA
  • Oxygen is not bad

24
Saturation Monitoring
  • Oxygen saturation reflects tissue oxygenation and
    usually does not correlate with PO2.
  • With pulmonary hypertension will see differential
    cyanosis - shunts right to left across the PDA.
  • The number is not as important as the patient.

25
Prostaglandin Infusion
  • Purpose is to open the PDA if a ductal dependent
    lesion is suspected
  • Can be initiated before a definitive diagnosis is
    established
  • Need a secure IV (PIV, PIC, or UVC-central or in
    the liver)
  • Start at low dose 0.03 mcg/kg/min

26
Prostaglandins continued
  • Side effects -
  • Apnea - be prepared to intubate
  • Fever
  • Hypotension - have volume and inotropes available
  • Flushing

27
Access
  • Umbilical is preferred in a newborn
  • UVC even if in suboptimal position
  • UAC
  • PIC line
  • PIV
  • AVOID groin line if possible

28
Fluid Resuscitation
  • Needed if poorly perfused
  • 5 albumin bolus (5-10 cc/kg)
  • Watch for and treat hypoglycemia - stress causes
    epinephrine release which increases utilization
    of glucose.
  • PRBC to treat anemia - optimize oxygen carrying
    capacity.

29
Hypotension
  • Check ionized calcium
  • Treat with 50-100mg/kg calcium gluconate or 10
    mg/kg calcium chloride via central access
  • Dopamine 3mcg/kg/min increase as needed (no
    higher than 10 mcg/kg/min)

30
Metabolic Acidosis
  • Treat metabolic acidosis aggressively (base
    deficit lt -3)
  • 1 meq/kg Na bicarbonate
  • Repeat blood gas

31
Other Systems
  • Renal function
  • Urine output
  • BUN/Cr
  • Renal ultrasound
  • Head ultrasound
  • Liver function tests
  • Coagulopathy
  • Thrombocytopenia
  • R/O sepsis
  • Genetics

32
Fetal Diagnosis
33
Fetal Studies
  • Hornberger, 1995 21 fetuses with prenatal echos
    that show left-sided obstruction (small mitral
    valve ascending aorta) developed HLHS.
  • Critical aortic stenosis ? decreased blood flow
    through left heart ? LV dilation dysfunction ?
    endocardial fibroelastosis (EFE) ? backwards flow
    across PFO ? LV stops growing eventually
    shrinks

34
HLHS
35
NORMAL FETAL 4-CHAMBER
36
(No Transcript)
37
Case Presentation
  • Term infant born via SVD
  • Uncomplicated labor and delivery
  • APGARs of 8 at 1min., 9 at 5min.
  • Tachypnea noted at 12hrs of life.

38
Case Presentation
  • Airway-Breathing-Circulation
  • Respiratory rate (60-90 bpm)
  • Work of breathing (no retractions)
  • Saturations (80)
  • Warm extremities good cap refill

39
Case Presentation
  • No obvious dysmorphic features.
  • More Cardiac Exam Findings
  • No murmur.
  • Single second heart sound (S2).
  • Hyperdynamic precordium.

40
Case Presentation
  • Urgent Cardiology Consult
  • 404-256-2593!!
  • Cardiac History Physical
  • Echocardiogram

41
Echocardiogram HLHS
42
(No Transcript)
43
Hypoplastic Left Heart Syndrome
44
Case Presentation
  • BUT
  • No beds available at Egleston immediately
  • Need to manage infant for 24 hours before
    transport
  • NOW what do we do?

45
Case Presentation
  • Intravenous access
  • UVC (double lumen)
  • UAC
  • PIV
  • PIC
  • Remember AVOID groin lines

46
Case Presentation
  • Prostaglandins
  • 0.03 mcg/kg/min
  • Side effects
  • Apnea
  • Options ?
  • Intubate vs nasal cannula air

47
Case Presentation
  • Labs
  • Arterial (or venous) blood gas
  • Electrolytes (normalize)
  • CBC
  • LFT
  • Genetics
  • Lactic acid
  • Head and Renal ultrasound
  • ECHO/EKG

48
Case Presentation
  • R/O Sepsis
  • If no clinical suspicion or maternal indicators
    no need to start antibiotics
  • Follow ABG frequently (Q 4 hrs)
  • Monitor urine output
  • Monitor for acidosis
  • Watch for hypotension

49
Blood Pressure
  • Blood pressure - systolic and diastolic blood
    pressures are equally importantnot just mean!!
  • Coronary flow to heart dependant on diastolic BP

50
Case Presentation
  • Saturations 95
  • pO2 50
  • Decreased urine output
  • Metabolic acidosis
  • Rising lactic acid
  • Whats going on?!?

51
Chest X-Ray
52
Case Presentation
  • Pulmonary Over Circulation with systemic
    compromise
  • Intubate/hypoventilate
  • CO2

53
Hypoplastic Left Heart Syndrome
54
Case Presentation
  • Y- tube Physiology

To Body
To Lungs
Pulmonary Resistance Lowered by - Oxygen -
Prostaglandin - Resp alkalosis Raised by -
PPV - Hypoxia - Resp acidosis
Systemic Resistance Raised by - Dopamine -
Epinephrine
55
Monitoring Innovations
  • Lactic Acid
  • Mixed venous oxygen saturation
  • Near infrared spectroscopy

56
Pulmonary Atresia
57
Hypoplastic RIGHT Heart
Flow begets growth
58
Same Y-tube Physiology
To Body
To Lungs
But now not enough blood flow to lungs
59
Ideal Saturation for PDA-dependant
  • For balanced amount of blood flow to both the
    lungs and the body in a single ventricle (i.e.
    Y-tube physiology infant) is
  • 75 to 85 oxygen saturation
  • (in upper extremity)

60
Options for HLHS in 2010
  • Comfort Care
  • Transplant
  • 3-Stage Palliative Repair
  • Fetal Intervention

61
Cardiac Transplant
  • Fairly good quality of life as transplant
    recipient (have structurally normal heart).
  • Obstacles
  • Availability of donor heart (approximately 25-30
    die awaiting transplant).
  • Life-long immunosuppression risk of
    infection/CA.
  • Usual cause of death/organ death coronary
    vasculopathy.
  • Survival 84 at 1 yr, 76 at 5 yrs., 70 at 7
    yrs.
  • Organ survival MUCH reduced w/subsequent
    transplants.

62
HLHS Palliative Repair
  • HLHS (sats 80s)
  • Norwood repair in 2wks
  • - Provide systemic BF
  • - Balance pulmonary BF
  • Glenn repair (SVC to PA)
  • - More pulmonary BF
  • Fontan repair (IVC to PA)
  • - Relieve volume load to RV
  • - Venous blood totally bypasses heart (sats 100)

63
Norwood (Stage I)
64
HLHS Survival
  • Standard Risk (i.e. no genetic or extracardiac
    issues)
  • 1 month 85
  • 1 year 80
  • 5 year 73
  • Higher Risk
  • 1 month 61
  • 1 year 20

65
Fetal Intervention
  • VERY small balloon catheter is inserted via
    mothers abdomen, across uterus, through fetal
    heart across aortic valve. Fetal aortic
    valvuloplasty is performed.
  • Marginal success with select patients
  • Must have diagnosis in early 2nd trimester
  • Absence of genetic or extracardiac anomalies
  • Early stage of critical aortic stenosis (LV is
    dilated with some preserved function, but not yet
    involuted)
  • Favorable maternal habitus

66
Comfort Care/Hospice
  • Why is it a viable option in 2010?
  • The Fontan is doomed to fail. Dr. Reddington,
    ACC 2003
  • Fontan patients will develop protein-losing
    enteropathy, ventricular dysfunction, hypoxemia,
    thromboembolism, arrhythmias and liver failure.

67
Why Fontans Fail
As we age, the ventricular EDP rises. In Fontan
patients, the CVP must exceed the EDP.
Eventually, the EDP will rise to an intolerable
level.
68
Summary
  • HLHS is universally lethal w/out treatment.
  • A patent foramen ovale ductus arteriosus are
    necessary for survival.
  • Echocardiogram is modality of choice for
    diagnosis.
  • Management of the neonate w/HLHS is complicated
    PGE is necessary as well as ventilation/support
    to permit sats 75 to 85 and no acidosis.
  • Transplant and staged repair are not w/out their
    complications (survival for both about 70 in 5
    yrs).
  • Comfort care fetal interventions are options to
    be considered.
  • Decision-making is a TEAM effort by pt. family
    medical team.

69
Thank You!
70
Questions ?
Write a Comment
User Comments (0)
About PowerShow.com